- Home
- IEP vs INSP Comparison
IEP vs INSP Comparison
Compare IEP & INSP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IEP
- INSP
- Stock Information
- Founded
- IEP 1987
- INSP 2007
- Country
- IEP United States
- INSP United States
- Employees
- IEP N/A
- INSP N/A
- Industry
- IEP Auto Parts:O.E.M.
- INSP Medical/Dental Instruments
- Sector
- IEP Consumer Discretionary
- INSP Health Care
- Exchange
- IEP Nasdaq
- INSP Nasdaq
- Market Cap
- IEP 4.7B
- INSP 3.8B
- IPO Year
- IEP 1987
- INSP 2018
- Fundamental
- Price
- IEP $8.36
- INSP $76.64
- Analyst Decision
- IEP
- INSP Buy
- Analyst Count
- IEP 0
- INSP 15
- Target Price
- IEP N/A
- INSP $155.79
- AVG Volume (30 Days)
- IEP 580.9K
- INSP 1.1M
- Earning Date
- IEP 11-07-2025
- INSP 11-03-2025
- Dividend Yield
- IEP 23.92%
- INSP N/A
- EPS Growth
- IEP N/A
- INSP 756.73
- EPS
- IEP N/A
- INSP 1.74
- Revenue
- IEP $9,533,000,000.00
- INSP $861,312,000.00
- Revenue This Year
- IEP N/A
- INSP $14.91
- Revenue Next Year
- IEP $0.69
- INSP $14.37
- P/E Ratio
- IEP N/A
- INSP $43.95
- Revenue Growth
- IEP N/A
- INSP 22.05
- 52 Week Low
- IEP $7.27
- INSP $70.77
- 52 Week High
- IEP $15.65
- INSP $216.01
- Technical
- Relative Strength Index (RSI)
- IEP 48.45
- INSP 39.89
- Support Level
- IEP $8.27
- INSP $70.77
- Resistance Level
- IEP $8.48
- INSP $78.41
- Average True Range (ATR)
- IEP 0.14
- INSP 3.05
- MACD
- IEP 0.04
- INSP 0.41
- Stochastic Oscillator
- IEP 68.29
- INSP 43.00
About IEP Icahn Enterprises L.P.
Icahn Enterprises LP provides diversified business services in the United States. The company operates its business through varied segments which include Investment, Automotive, Energy, Food Packaging, Real Estate, Pharma, and Home Fashion. Among these, the Energy segment derives the maximum revenue from the company. Geographically, it generates maximum revenue from the United States.
About INSP Inspire Medical Systems Inc.
Inspire Medical Systems Inc operates as a medical technology company. It focuses on the development and commercialization of minimally invasive solutions for patients with obstructive sleep apnea (OSA). It offers Inspire system, a neurostimulation technology that provides a safe and effective treatment for moderate to severe obstructive sleep apnea. The firm has operating footprints in the United States and Europe wherein, it generates a majority of its revenue from the United States.